Evofem Biosciences, Inc. (EVFM) Financials

EVFM Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 7.5 million 90.0 million
March 31, 2026 7.4 million 80.2 million
Dec. 31, 2025 20.3 million 89.7 million
Sept. 30, 2025 13.8 million 84.0 million

EVFM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.1 million ?
March 31, 2026 2.3 million 15000
Dec. 31, 2025 28000 42000
Sept. 30, 2025 336000 23000

EVFM Net Income

No data available :(

EVFM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 285000 4000 4000
March 31, 2026 2.4 million 27000 150000
Dec. 31, 2025 578000 - 54000
Sept. 30, 2025 840000 - 196000

EVFM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 ?
March 31, 2026 ?
Dec. 31, 2025 ?
Sept. 30, 2025 ?

EVFM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 694000 3.9 million 2.1 million
March 31, 2026 2000 518000 4.5 million 2.1 million
Dec. 31, 2025 3000 -2.8 million 3.2 million 2.1 million
Sept. 30, 2025 - 470000 4.5 million 2.4 million

EVFM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 2.6 million 525000
March 31, 2026 899000 485000
Dec. 31, 2025 9.6 million 3.0 million
Sept. 30, 2025 5.0 million 985000

EVFM

Price: $0.01

52 week price:
0.00
0.02

Payout Ratio Range:
-7.07%
0.07%

Earnings Per Share: -0.05 USD

P/E Ratio: -0.18

Exchange: OQB

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 2.6 million

Ebitda: -1.8 million

Market Capitalization: 980722

Links: